Avinger Completes Enrollment in SCAN Clinical Study
23 août 2018 08h30 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., Aug. 23, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it has...
Avinger Announces Second Quarter 2018 Financial Results
13 août 2018 16h00 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., Aug. 13, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today reported results for the...
Avinger to Report Second Quarter 2018 Results on Monday, August 13, 2018
06 août 2018 10h30 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., Aug. 06, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq: AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), will announce its second...
Avinger Announces Pricing of $3.55 Million Registered Direct Offering
12 juil. 2018 08h30 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., July 12, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that it has...
Avinger Appoints Jaafer Golzar, MD, FACC, FSCAI, as Chief Medical Officer
10 juil. 2018 08h30 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., July 10, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced the...
Avinger Announces Successful Treatment of First Patients with Next-Generation Pantheris in Several Centers throughout the US
26 juin 2018 08h30 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., June 26, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that several...
Avinger’s Ocelot Technology Featured in Live Case Transmission at Complex Cardiovascular Catheter Therapeutics (C3) 2018
21 juin 2018 08h30 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., June 21, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced that its Ocelot...
Avinger Announces First Patients Enrolled in Post-Market Study Comparing Pantheris OCT Imaging to Intravascular Ultrasound
14 juin 2018 08h30 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., June 14, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced the initiation...
Avinger Appoints Mark Weinswig as Chief Financial Officer
13 juin 2018 08h30 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., June 13, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (NASDAQ:AVGR) (“Avinger” or the “Company”), a leading developer of innovative treatments for peripheral artery disease (PAD),...
Avinger Announces Presentations and Posters Featuring Lumivascular Technology at New Cardiovascular Horizons Annual Conference
30 mai 2018 08h30 HE
|
Avinger, Inc.
REDWOOD CITY, Calif., May 30, 2018 (GLOBE NEWSWIRE) -- Avinger, Inc. (Nasdaq:AVGR), a leading developer of innovative treatments for peripheral artery disease (PAD), today announced a schedule of...